Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term Use
Post-marketing surveillance study assessing long-term use of Micombi Tablets in hypertension has completed. The results were posted in 2013.
-
FDA approval · 2013-01-29FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's supplemental application for Hydralazine Hydrochloride, marking an approved supplement to the product's existing approva…
-
FDA approval · 2013-01-28FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for Losartan Potassium and Hydrochlorothiazide (a generic combination therapy), submitted by NorthSt…
-
FDA approval · 2013-01-28FDA Approved: HYDRALAZINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approves a supplemental application for hydralazine hydrochloride from Teva Pharmaceuticals USA, Inc. (generic) under an Abbreviated New…
-
FDA approval · 2013-01-28FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approves a supplemental application for Losartan Potassium from Macleods Pharmaceuticals Limited (ANDA202230), authorizing the generic p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study) [Phase 4]
Phase 4 COLM-Study evaluating the combination of olmesartan with a calcium channel blocker or a low-dose diuretic in high-risk elderly hyper…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Exercise Training in Type 2 Diabetes and Hypertension [Phase 4]
This update notes completion of a Phase 4 trial evaluating the effects of exercise training in people with type 2 diabetes mellitus and hype…
-
CLINICAL_TRIALS research · 2013-01-23Clinical Trial Update: Effect of Gene Variants on Dopamine Receptor Natriuretic Responses [Phase 1]
A Phase 1 clinical trial update from University of Virginia examining how genetic variants influence dopamine receptor–mediated natriuretic …
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Relationship of Urine Sodium Excretion to Central Blood Pressure and Aortic Pulse Wave Velocity
A completed DongGuk University trial examined the relationship between urine sodium excretion and central blood pressure and aortic pulse wa…
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: A Study to Evaluate the Effects of Manidipine Versus Amlodipine and the Combination of Manidipine Plus Delapril Versus Amlodipine Plus Delapril on Intraglomerular Pressure in Hypertensive Patients [Phase 3]
Phase 3 trial comparing manidipine to amlodipine and the combination of manidipine with delapril to amlodipine with delapril in hypertensive…
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine Monotherapy [Phase 3]
Phase 3 trial evaluating the efficacy and safety of the fixed-dose combination irbesartan/amlodipine in hypertensive patients uncontrolled o…
-
CLINICAL_TRIALS research · 2013-01-18Clinical Trial Update: CPAP and Nebivolol in Hypertensive Obstructive Sleep Apnea (OSA) Patients. [Phase 4]
Phase 4 clinical trial update evaluating CPAP and Nebivolol in hypertensive patients with obstructive sleep apnea and endothelial dysfunctio…
-
FDA approval · 2013-01-17FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (TruPharma, LLC)
FDA approved a supplemental application for clonidine hydrochloride from TruPharma, LLC. This action indicates regulatory approval of a supp…
-
FDA approval · 2013-01-17FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for clonidine hydrochloride from Alembic Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2013-01-17Clinical Trial Update: Genetic Epidemiology of Responses to Antihypertensives
A completed clinical trial update examining genetic factors that influence how patients respond to antihypertensive medications. The study i…
-
FDA approval · 2013-01-17FDA Approved: FELODIPINE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's Original Application for Felodipine, authorizing the marketing of a generic felodipine product.
-
FDA approval · 2013-01-16FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for clonidine hydrochloride from Actavis Pharma, Inc., indicating an approved modification to an…
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia
A completed centralised Pan-Algerian survey evaluating undertreatment of hypercholesterolemia and related cardiovascular conditions.
-
FDA approval · 2013-01-11FDA Approved: DURACLON — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for DURACLON (clonidine hydrochloride) from Mylan Institutional LLC, adding to the existing approved…
-
FDA approval · 2013-01-10FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Nicardipine hydrochloride from Hikma Pharmaceuticals USA Inc., granting regulatory approval …
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Effectiveness of Yoga on Ambulatory Blood Pressure in Patients With Pre- and Stage I Hypertension [NA]
This update notes the completion of a clinical trial evaluating the effectiveness of yoga on ambulatory blood pressure in adults with prehyp…
-
CLINICAL_TRIALS research · 2013-01-10Clinical Trial Update: Attitudes and Understanding of Sodium Claims on Food Labels
This clinical trial update investigates how people with hypertension perceive and understand sodium-related claims on food labels.
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Bevacizumab and Endothelium Dependent Vasodilation [NA]
Bevacizumab trial focusing on endothelium-dependent vasodilation has completed, with Radboud University Medical Center as sponsor and condit…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Effect of Different Doses of Tomato Lycopene on Blood Pressure in Pre-hypertensive Otherwise Healthy Subjects [NA]
A terminated clinical trial assessing whether different doses of tomato lycopene affect blood pressure in pre-hypertensive, otherwise health…
-
FDA approval · 2013-01-07FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for NORVASC (amlodipine besylate) submitted by Viatris Specialty LLC. The approval is related to…